Published in Vaccine on October 26, 2007
Progress in understanding and controlling respiratory syncytial virus: still crazy after all these years. Virus Res (2011) 2.51
Human Metapneumovirus: lessons learned over the first decade. Clin Microbiol Rev (2011) 1.38
How innate immune mechanisms contribute to antibody-enhanced viral infections. Clin Vaccine Immunol (2010) 1.23
Respiratory viruses and eosinophils: exploring the connections. Antiviral Res (2009) 1.06
Pulmonary eosinophils and their role in immunopathologic responses to formalin-inactivated pneumonia virus of mice. J Immunol (2009) 0.96
Modulation of protease activated receptor 1 influences human metapneumovirus disease severity in a mouse model. PLoS One (2013) 0.88
Human metapneumovirus virus-like particles induce protective B and T cell responses in a mouse model. J Virol (2014) 0.85
Human metapneumovirus in adults. Viruses (2013) 0.81
Bioinformatics in new generation flavivirus vaccines. J Biomed Biotechnol (2010) 0.81
Lung CD8+ T Cell Impairment Occurs during Human Metapneumovirus Infection despite Virus-Like Particle Induction of Functional CD8+ T Cells. J Virol (2015) 0.80
Host proteome correlates of vaccine-mediated enhanced disease in a mouse model of respiratory syncytial virus infection. J Virol (2015) 0.79
New Approaches for Immunization and Therapy against Human Metapneumovirus. Clin Vaccine Immunol (2015) 0.79
A live attenuated human metapneumovirus vaccine strain provides complete protection against homologous viral infection and cross-protection against heterologous viral infection in BALB/c mice. Clin Vaccine Immunol (2013) 0.79
Serologic cross-reactions between nucleocapsid proteins of human respiratory syncytial virus and human metapneumovirus. J Clin Microbiol (2015) 0.77
Modulation of Host Immunity by the Human Metapneumovirus. Clin Microbiol Rev (2016) 0.75
Novel HLA-A2-restricted human metapneumovirus epitopes reduce viral titers in mice and are recognized by human T cells. Vaccine (2016) 0.75
Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med (2003) 27.97
Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med (2012) 22.75
Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science (2003) 18.34
Mapping the antigenic and genetic evolution of influenza virus. Science (2004) 14.28
Global patterns of influenza a virus in wild birds. Science (2006) 13.80
Airborne transmission of influenza A/H5N1 virus between ferrets. Science (2012) 13.48
Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome. Proc Natl Acad Sci U S A (2004) 12.39
Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls. J Virol (2005) 10.77
The global circulation of seasonal influenza A (H3N2) viruses. Science (2008) 10.05
Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans. MBio (2012) 8.54
Pathogenesis and transmission of swine-origin 2009 A(H1N1) influenza virus in ferrets. Science (2009) 7.80
Aetiology: Koch's postulates fulfilled for SARS virus. Nature (2003) 7.51
The severe acute respiratory syndrome. N Engl J Med (2003) 7.48
Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. Lancet (2003) 6.52
Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature (2013) 6.39
H5N1 Virus Attachment to Lower Respiratory Tract. Science (2006) 6.34
Avian influenza H5N1 in tigers and leopards. Emerg Infect Dis (2004) 6.16
Spatial, temporal, and species variation in prevalence of influenza A viruses in wild migratory birds. PLoS Pathog (2007) 6.04
Human bocavirus and acute wheezing in children. Clin Infect Dis (2007) 5.88
A previously undescribed coronavirus associated with respiratory disease in humans. Proc Natl Acad Sci U S A (2004) 5.76
Characterization of human metapneumoviruses isolated from patients in North America. J Infect Dis (2002) 5.64
Avian H5N1 influenza in cats. Science (2004) 5.40
Human and avian influenza viruses target different cells in the lower respiratory tract of humans and other mammals. Am J Pathol (2007) 4.86
Analysis of the genomic sequence of a human metapneumovirus. Virology (2002) 4.64
Clearance of influenza virus from the lung depends on migratory langerin+CD11b- but not plasmacytoid dendritic cells. J Exp Med (2008) 3.97
Human coronavirus EMC does not require the SARS-coronavirus receptor and maintains broad replicative capability in mammalian cell lines. MBio (2012) 3.96
Virology: SARS virus infection of cats and ferrets. Nature (2003) 3.86
Gain-of-function experiments on H7N9. Science (2013) 3.67
Metapneumovirus and acute wheezing in children. Lancet (2002) 3.64
Dengue virus pathogenesis: an integrated view. Clin Microbiol Rev (2009) 3.61
The potential for respiratory droplet-transmissible A/H5N1 influenza virus to evolve in a mammalian host. Science (2012) 3.50
Substitutions near the receptor binding site determine major antigenic change during influenza virus evolution. Science (2013) 3.38
Wild ducks as long-distance vectors of highly pathogenic avian influenza virus (H5N1). Emerg Infect Dis (2008) 3.37
Antigenic and genetic variability of human metapneumoviruses. Emerg Infect Dis (2004) 2.96
Prevalence and clinical symptoms of human metapneumovirus infection in hospitalized patients. J Infect Dis (2003) 2.91
Mallards and highly pathogenic avian influenza ancestral viruses, northern Europe. Emerg Infect Dis (2005) 2.90
Real-time reverse transcriptase PCR assay for detection of human metapneumoviruses from all known genetic lineages. J Clin Microbiol (2004) 2.88
Severity of pneumonia due to new H1N1 influenza virus in ferrets is intermediate between that due to seasonal H1N1 virus and highly pathogenic avian influenza H5N1 virus. J Infect Dis (2010) 2.81
Influenza A virus (H5N1) infection in cats causes systemic disease with potential novel routes of virus spread within and between hosts. Am J Pathol (2006) 2.77
Surveillance of influenza A virus in migratory waterfowl in northern Europe. Emerg Infect Dis (2007) 2.76
Cochrane re-arranged: support for policies to vaccinate elderly people against influenza. Vaccine (2013) 2.69
Effects of influenza A virus infection on migrating mallard ducks. Proc Biol Sci (2009) 2.69
Respiratory picornaviruses and respiratory syncytial virus as causative agents of acute expiratory wheezing in children. Emerg Infect Dis (2004) 2.68
The molecular basis of the pathogenicity of the Dutch highly pathogenic human influenza A H7N7 viruses. J Infect Dis (2007) 2.58
Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza viruses. Vaccine (2008) 2.56
Efficient generation and growth of influenza virus A/PR/8/34 from eight cDNA fragments. Virus Res (2004) 2.43
Avian flu: Gain-of-function experiments on H7N9. Nature (2013) 2.32
Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques. Nat Med (2004) 2.31
Pause on avian flu transmission research. Science (2012) 2.24
In vitro assessment of attachment pattern and replication efficiency of H5N1 influenza A viruses with altered receptor specificity. J Virol (2010) 2.23
Cross-protection against lethal H5N1 challenge in ferrets with an adjuvanted pandemic influenza vaccine. PLoS One (2008) 2.20
Acyclovir prophylaxis predisposes to antiviral-resistant recurrent herpetic keratitis. J Infect Dis (2013) 2.19
Introduction of virulence markers in PB2 of pandemic swine-origin influenza virus does not result in enhanced virulence or transmission. J Virol (2010) 2.19
Virulence-associated substitution D222G in the hemagglutinin of 2009 pandemic influenza A(H1N1) virus affects receptor binding. J Virol (2010) 2.17
Limited airborne transmission of H7N9 influenza A virus between ferrets. Nature (2013) 2.17
Selective retention of herpes simplex virus-specific T cells in latently infected human trigeminal ganglia. Proc Natl Acad Sci U S A (2007) 2.13
Dendritic cells are crucial for maintenance of tertiary lymphoid structures in the lung of influenza virus-infected mice. J Exp Med (2009) 2.12
Modified vaccinia virus Ankara protects macaques against respiratory challenge with monkeypox virus. J Virol (2005) 2.11
Predominant infection of CD150+ lymphocytes and dendritic cells during measles virus infection of macaques. PLoS Pathog (2007) 2.09
Response to imported case of Marburg hemorrhagic fever, the Netherland. Emerg Infect Dis (2009) 2.07
Population dynamics of rapid fixation in cytotoxic T lymphocyte escape mutants of influenza A. Proc Natl Acad Sci U S A (2003) 2.03
Molecular determinants of adaptation of highly pathogenic avian influenza H7N7 viruses to efficient replication in the human host. J Virol (2009) 1.99
Carriage of Mycoplasma pneumoniae in the upper respiratory tract of symptomatic and asymptomatic children: an observational study. PLoS Med (2013) 1.95
Identification of a naturally occurring recombinant genotype 2/6 hepatitis C virus. J Virol (2006) 1.90
Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides. Proc Natl Acad Sci U S A (2004) 1.89